Skip to main content
Caplight Logo









Redefine Surgery

Redefine Surgery

Private
Hoboken, New JerseyHealthcare & Life Scienceshttps://redefinesurgery.com

Last Round

Pre Seed

Sep 24, 2026

Total Funding Raised

$10.22M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Redefine Surgery operates in Healthcare & Life Sciences and is based in Hoboken, New Jersey. Its latest recorded funding round was a Pre Seed round in September 2026.

Redefine Surgery is a health technology company that is developing an AI-powered, immersive 3D platform to enhance surgical training, education, and precision.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Computer Vision, Industrial Robotics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Redefine Surgery Comparables

Compare Redefine Surgery with similar companies based on industry and business-model similarity.

Redefine Surgery comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VISIE Inc.
82%
Activ Surgical
75%
Proprio
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Redefine Surgery Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 24, 2026
GrantFeb 4, 2025
AcceleratorSep 8, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Peter Verrillo

Chief Executive Officer

Executive Team

Stephen Potter

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Redefine Surgery Investors

Notable investors and investment history

Redefine Surgery investors
InvestorRounds
TechstarsAccelerator
Massachusetts Technology CollaborativeGrant
MassRoboticsGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 24, 2026

    $10M raised in Pre Seed round.

  • Jan 7, 2026

    Grew 32% QoQ, from 22 to 29 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • is_developingSep 25, 2026

    On Sep 24th '26, Redefine Surgery announces an oversubscribed Pre-Seed financing that brings total capital raised to $10M as it develops a computer-vision, artificial-intelligence, and robotics platform for orthopedic surgery, which remains under development and is not commercially available or FDA-cleared.

  • is_developingSep 25, 2026

    Redefine Surgery is developing Collaborative Surgical Intelligence, a platform combining computer vision, AI, and robotics to support surgical navigation, smarter instruments, real-time guidance, and learning from procedures while keeping surgeons in control; the product remains under development, is not commercially available, and is not cleared by the U.S. Food and Drug Administration.

  • receives_financingSep 24, 2026

    Redefine Surgery received financing of $10M in Pre Seed on Sep 24th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Redefine Surgery Filings

Explore SEC and related filing metadata, where available.

Redefine Surgery filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Redefine Surgery's valuation, stock price, and market status.

Is Redefine Surgery a public or private company?

Redefine Surgery is a private company.

What is the current stock price of Redefine Surgery?

Redefine Surgery is a private company, so its shares have no public market price. Caplight tracks Redefine Surgery's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Redefine Surgery worth (valuation)?

Valuation information for Redefine Surgery is not publicly available.

Can I buy Redefine Surgery stock?

Redefine Surgery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Redefine Surgery's last funding round?

Redefine Surgery's most recent funding round was Pre Seed on September 24, 2026.

Who are the main investors in Redefine Surgery?

Key investors in Redefine Surgery include Techstars, MassRobotics.

Will Redefine Surgery IPO soon?

No public IPO plans have been announced for Redefine Surgery.

How can I track Redefine Surgery secondary market activity?

Caplight tracks bids, offers, and trades in Redefine Surgery's shares on secondary markets.

Firmographic Details

HeadquartersHoboken, New Jersey
Employee Range25
Year Founded2023
Last FundingSep 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?